Muhammad Ahmar Khan

Dr Khan is a public health professional with a dedicated focus on addressing antimicrobial resistance (AMR). His recent AMR-related work includes:

He is currently leading a three-year ICARS-supported antimicrobial stewardship project that combines tailored staff training with a digital mobile application. His ongoing PhD at the University of Leeds, UK, evaluates this intervention through a cluster randomised controlled trial, accompanied by a process evaluation and costing studies.

Dr. Khan supports MDR-Tuberculosis care at thirteen GFATM-supported DR-TB clinics in Punjab, Pakistan, providing free-of-cost services to more than 1,200 patients annually. His work includes diagnosis, treatment, and social support, as well as the implementation of BPaL/M (all-oral shorter regimen) at over 40 DR-TB clinics in Pakistan, supported by TB Alliance. He has also contributed to two WHO-assisted implementation research projects on all-oral shorter regimens for DR-TB.

In addition, Dr. Khan has facilitated the development and implementation of OneImpact (Stop TB Partnership) to engage DR-TB survivors in responsive care at clinics in Punjab. This digital tool enhances patient support through knowledge access, challenge reporting, peer networks, and patient–provider forums. Through his work, Dr. Khan bridges research, program delivery, and system strengthening to advance evidence-based AMR solutions.